Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 25INDUSTRY 5NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Burkitt Lymphoma 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, AIDS-Related 1

Interventions

Rituximab 13Cyclophosphamide 12Vincristine 11Prednisone 11Doxorubicin 8Radiotherapy 6Immunohistochemistry 5VAP-cyclo protocol 4Peripheral Blood Stem Cell Transplantation 4Gene Expression Profiling 4Etoposide 4Amplified Fragment Length Polymorphism Analysis 4tositumomab I-131 3Polymerase Chain Reaction 3Microarray Analysis 3Methotrexate 3Cytarabine 3Melphalan 2Interferon-alpha 2Filgrastim 2Carmustine 2Bortezomib 2Bendamustine Hydrochloride 2thymoglobulin 1sargramostim 1pegfilgrastim 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Follicular × ibritumomab tiuxetan × Clear all
NCT00310128 2016-02-03

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, AIDS-Related, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡